|
| |
| | | | 1 | | | DO1.PCCNTR.2306648 ContractData Container |
| | | 1.1 | | | | | | | | | | 975,048,659.00 | 0.00 | 0.00 | 0.00 | 980,473,685.00 | 975,048,659.00 |
|
| | | | | | | 2 | | 2.3.4.1.01 | ATEZOLIZUMAB 1200 mg / 20 ml | 416 | UD | 382,000 | 401,100 | 166,857,600.00 | | 0.00 | | | 0.00 | | 0.00 | 158,912,000.00 | 166,857,600.00 | |
|
| | | | | | | 4 | | 2.3.4.1.01 | EMICIZUMAB 105mg /0.7ml | 863 | UD | 400,000 | 400,000 | 345,200,000.00 | | 0.00 | | | 0.00 | | 0.00 | 345,200,000.00 | 345,200,000.00 | |
|
| | | | | | | 5 | | 2.3.4.1.01 | EMICIZUMAB 30 mg/ 1 ml | 804 | UD | 117,000 | 117,000 | 94,068,000.00 | | 0.00 | | | 0.00 | | 0.00 | 94,068,000.00 | 94,068,000.00 | |
|
| | | | | | | 9 | | 2.3.4.1.01 | OBINUTUZUMAB 1000 mg / 40 ml | 100 | UD | 99,800 | 104,800 | 10,480,000.00 | | 0.00 | | | 0.00 | | 0.00 | 9,980,000.00 | 10,480,000.00 | |
|
| | | | | | | 10 | | 2.3.4.1.01 | OCRELIZUMAB 300 mg / 10 ml | 467 | UD | 459,175 | 459,175 | 214,434,725.00 | | 0.00 | | | 0.00 | | 0.00 | 214,434,725.00 | 214,434,725.00 | |
|
| | | | | | | 20 | | 51201569 - Atlizumab o to(...)51201569 - Atlizumab o tocilizumab |
| 2.3.4.1.01 | TOCILIZUMAB 162 mg / 0.9 ml | 2,364 | UD | 11,815 | 10,633.5 | 25,137,594.00 | | 0.00 | | | 0.00 | | 0.00 | 27,930,660.00 | 25,137,594.00 | |
|
| | | | | | | 21 | | 51201569 - Atlizumab o to(...)51201569 - Atlizumab o tocilizumab |
| 2.3.4.1.01 | TOCILIZUMAB 200 mg / 10 ml | 7,101 | UD | 18,300 | 16,740 | 118,870,740.00 | | 0.00 | | | 0.00 | | 0.00 | 129,948,300.00 | 118,870,740.00 | |
|
|
| | | |
| | | |
|